☰

Christopher B. Weldon, Ph.D. - Publications

Affiliations: 
2004 Tulane University, New Orleans, LA, United States 
Area:
Pharmacology, Oncology
Tree Info Grants Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Liu KX, Collins NB, Greenzang KA, Furutani E, Campbell K, Groves A, Mullen EA, Shusterman S, Spidle J, Marcus KJ, Weil BR, Weldon CB, Frazier AL, Janeway KA, O'Neill AF, et al. The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatric Blood & Cancer. e28559. PMID 32686305 DOI: 10.1002/Pbc.28559  0.326
2019 Dieffenbach BV, Li N, Madenci AL, Barnea D, Murphy AJ, Tonorezos ES, Gibson TM, Liu Q, Leisenring W, Howell RM, Diller L, Armstrong GT, Yasui Y, Oeffinger KC, Weldon CB, et al. Late cholecystectomy in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 37: e21525-e21525. DOI: 10.1200/Jco.2019.37.15_Suppl.E21525  0.3
2017 O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, et al. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017735654. PMID 28892430 DOI: 10.1200/Jco.2017.73.5654  0.313
2016 Weldon CB, Madenci AL, Boikos SA, Janeway KA, George S, von Mehren M, Pappo AS, Schiffman JD, Wright J, Trent JC, Pacak K, Stratakis CA, Helman LJ, La Quaglia MP. Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016686733. PMID 28029307 DOI: 10.1200/Jco.2016.68.6733  0.302
2016 Mullassery D, Weldon CB. Pediatric/"Wildtype" gastrointestinal stromal tumors. Seminars in Pediatric Surgery. 25: 305-310. PMID 27955734 DOI: 10.1053/J.Sempedsurg.2016.09.004  0.323
2016 Madenci AL, Levine BS, Laufer MR, Boyd TK, Voss SD, Frazier AL, Weldon CB. Poor adherence to staging guidelines for children with malignant ovarian tumors. Journal of Pediatric Surgery. PMID 27125730 DOI: 10.1016/J.Jpedsurg.2016.03.015  0.304
2012 Frazier AL, Weldon C, Amatruda J. Fetal and neonatal germ cell tumors. Seminars in Fetal & Neonatal Medicine. 17: 222-230. PMID 22647545 DOI: 10.1016/J.Siny.2012.05.004  0.304
2012 Collins-Burow BM, Antoon JW, Frigo DE, Elliott S, Weldon CB, Boue SM, Beckman BS, Curiel TJ, Alam J, McLachlan JA, Burow ME. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. The Journal of Steroid Biochemistry and Molecular Biology. 132: 186-93. PMID 22634477 DOI: 10.1016/J.Jsbmb.2012.05.004  0.701
2012 Janeway KA, Weldon CB. Pediatric gastrointestinal stromal tumor. Seminars in Pediatric Surgery. 21: 31-43. PMID 22248968 DOI: 10.1053/J.Sempedsurg.2011.10.003  0.31
2011 Klein JD, Turner CG, Gray FL, Yu DC, Kozakewich HP, Perez-Atayde AR, Voss SD, Zurakowski D, Shamberger RC, Weldon CB. Adrenal cortical tumors in children: factors associated with poor outcome. Journal of Pediatric Surgery. 46: 1201-7. PMID 21683223 DOI: 10.1016/J.Jpedsurg.2011.03.052  0.33
2011 Mariño-Enríquez A, Ou WB, Weldon CB, Fletcher JA, Pérez-Atayde AR. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes, Chromosomes & Cancer. 50: 146-53. PMID 21213368 DOI: 10.1002/Gcc.20839  0.317
2011 Doll KM, Weldon CB, Trosman JR, Wetzel HH, Fallen TJ, Gradishar WJ, Schink JC. BRCA+ test result impact and timing on surgical treatment decisions for patients with breast cancer. Journal of Clinical Oncology. 29: 626-626. DOI: 10.1200/Jco.2011.29.15_Suppl.626  0.313
2011 Schink JC, Doll KM, Weldon CB, Trosman JR, Wetzel HH, Fallen TJ, Gradishar WJ. Prophylactic oophorectomy for patients with breast cancer with BRCA results. Journal of Clinical Oncology. 29: 1533-1533. DOI: 10.1200/Jco.2011.29.15_Suppl.1533  0.312
2010 Bratton MR, Duong BN, Elliott S, Weldon CB, Beckman BS, McLachlan JA, Burow ME. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. International Journal of Oncology. 37: 541-50. PMID 20664923 DOI: 10.3892/Ijo_00000703  0.643
2008 Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, et al. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Research : Bcr. 10: R105. PMID 19087274 DOI: 10.1186/Bcr2210  0.61
2008 Weldon CB, Shamberger RC. Pediatric pulmonary tumors: primary and metastatic. Seminars in Pediatric Surgery. 17: 17-29. PMID 18158138 DOI: 10.1053/J.Sempedsurg.2007.10.004  0.308
2006 Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S, Collins-Burow BM, Salvo VA, Zhu Y, Melnik LI, Lopez GN, Kushner PJ, Curiel TJ, Rowan BG, McLachlan JA, et al. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Molecular Endocrinology (Baltimore, Md.). 20: 971-83. PMID 16410316 DOI: 10.1210/Me.2004-0075  0.322
2005 Weldon CB, McKee A, Collins-Burow BM, Melnik LI, Scandurro AB, McLachlan JA, Burow ME, Beckman BS. PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. International Journal of Oncology. 26: 763-8. PMID 15703835 DOI: 10.3892/Ijo.26.3.763  0.643
2004 Weldon CB, Elliott S, Zhu Y, Clayton JL, Curiel TJ, Jaffe BM, Burow ME. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators. Surgery. 136: 346-54. PMID 15300201 DOI: 10.1016/J.Surg.2004.05.010  0.382
2004 Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. International Journal of Oncology. 24: 1473-80. PMID 15138590 DOI: 10.3892/Ijo.24.6.1473  0.634
2003 Simstein R, Burow M, Parker A, Weldon C, Beckman B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Experimental Biology and Medicine (Maywood, N.J.). 228: 995-1003. PMID 14530507 DOI: 10.1177/153537020322800903  0.637
2002 Weldon CB, Jaffe BM, Kahn MJ. Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem. Annals of Surgical Oncology. 9: 738-44. PMID 12374656 DOI: 10.1007/Bf02574495  0.3
2002 Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery. 132: 293-301. PMID 12219026 DOI: 10.1067/Msy.2002.125389  0.576
2001 Burow ME, Weldon CB, Tang Y, McLachlan JA, Beckman BS. Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. The Journal of Steroid Biochemistry and Molecular Biology. 78: 409-18. PMID 11738551 DOI: 10.1016/S0960-0760(01)00117-0  0.631
2001 Weldon CB, Burow ME, Rolfe KW, Clayton JL, Jaffe BM, Beckman BS. NF-κB-mediated chemoresistance in breast cancer cells Surgery. 130: 143-150. PMID 11490342 DOI: 10.1067/Msy.2001.115512  0.621
2000 Burow ME, Weldon CB, Chiang TC, Tang Y, Collins-Burow BM, Rolfe K, Li S, McLachlan JA, Beckman BS. Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. International Journal of Oncology. 16: 1179-87. PMID 10811993 DOI: 10.3892/Ijo.16.6.1179  0.637
2000 Burow ME, Weldon CB, Melnik LI, Duong BN, Collins-Burow BM, Beckman BS, McLachlan JA. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochemical and Biophysical Research Communications. 271: 342-5. PMID 10799299 DOI: 10.1006/Bbrc.2000.2626  0.624
2000 Burow ME, Weldon CB, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Beckman BS. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. The Journal of Biological Chemistry. 275: 9628-35. PMID 10734114 DOI: 10.1074/Jbc.275.13.9628  0.624
1998 Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, Beckman BS. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Research. 58: 4940-6. PMID 9810003  0.588
Show low-probability matches.